Head/Neck Cancer News

Lymphatic fluid from surgical drains could offer important insights to guide treatment for certain patients with head and neck cancer, according to study results.

Survivors of head and neck cancer had an elevated risk for stroke — regardless of age, disease site or treatment modality — study findings published in JAMA Network Open showed.

More than 130,000 cancer cases went undiagnosed during the first 10 months of the COVID-19 pandemic, researchers estimated in a cross-sectional analysis published in JAMA Oncology.

Smokers and heavy drinkers had increased risk for head and neck cancer, whereas healthy eating slightly decreased risk, according to study data published in JAMA Otolaryngology-Head & Neck Surgery.

Limiting eligibility criteria, recruiting trusted community messengers and reducing financial burdens can help improve diversity of clinical trial enrollees, a panel of professionals said during a Friends of Cancer Research webinar.

In 1999, the FDA approved the Medtronic MiniMed as the first continuous glucose monitor for people with diabetes. In the 25 years since that approval, use of diabetes technology has gradually increased.

Use of subjective minimizing terminology, such as “safe” and “tolerable,” when discussing treatment-related toxicities occurs frequently at oncology and hematology conferences, according to a study published in Journal of Cancer Policy.

The increased treatment of patients with HPV-related oropharyngeal squamous cell carcinoma at community cancer centers is linked to poorer survival outcomes, according to data published in Journal of the National Cancer Institute.

As the broader health care field strives to identify and address health care disparities, a commentary published in The Lancet Oncology underscored the importance of eliminating ableism from cancer care.

The proportion of individuals with newly diagnosed cancer who lacked insurance in the U.S. declined significantly from 2010 to 2019, according to data published in Health Affairs Scholar.